Brief: Pharmasimple FY Revenue Down At EUR 30.0 Mln

Pharmasimple SA

13/04/2022 17:27

April 13 (Reuters) - Pharmasimple SA  ALPHS.PA :
    * ANNUAL RESULTS 2021
    * 2021 SALES AMOUNT TO EUR 30.0 MILLION, DECREASE OF 34%
COMPARED
YEAR AGO
    * 2021 GROSS MARGIN WAS 3.4 MILLION EURO
    * EBITDA SHOWS LOSS OF 5.4 MILLION EUR, OPERATING RESULT
IMPACTED
BY DEPRECIATION
    * 2021 NET RESULT SHOWS DEFICIT OF 9.1 MILLION EUR
    * OUTLOOK: FURTHER ACQUISITIONS ARE EXPECTED TO TAKE PLACE
DURING
2022
    * OUTLOOK: INTENDS TO LEVERAGE STRONG SYNERGIES COMBINING
ONLINE
EXPERTISE WITH TRADITIONAL PHARMACIES, INTERACTIVE KIOSKS IN
SHOPPING CENTERS
    * OUTLOOK: ONLINE/OFFLINE MIX SHOULD MAKE IT POSSIBLE TO
COMBINE
DIGITAL ADVANTAGES WITH ROBUSTNESS OF PHARMACY BUSINESS MODEL

Source text for Eikon:  ID:nACT73977 
Further company coverage:  ALPHS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))